0001127602-21-023776.txt : 20210816 0001127602-21-023776.hdr.sgml : 20210816 20210816161535 ACCESSION NUMBER: 0001127602-21-023776 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nikel Chad M. CENTRAL INDEX KEY: 0001877325 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 211178376 MAIL ADDRESS: STREET 1: C/O HAEMONETICS CORPORATION STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0402 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2021-08-06 0 0000313143 HAEMONETICS CORP HAE 0001877325 Nikel Chad M. 125 SUMMER STREET BOSTON MA 02110 1 President, Global Plasma & BC Common Stock 17336 D Non-qualified Stock Option (Right to Buy) 56.57 2028-05-18 Common Stock 8966 D Non-qualified Stock Option (Right to Buy) 103.37 2027-05-18 Common Stock 5319 D Non-qualified Stock Option (Right to Buy) 98.025 2026-05-14 Common Stock 5342 D Non-qualified Stock Option (Right to Buy) 93.52 2025-06-11 Common Stock 4282 D Non-qualified Stock Option (Right to Buy) 41.64 2024-06-06 Common Stock 1968 D 12,187 securities are in the form of unvested restricted stock units ("RSUs") issued pursuant to the Issuer's 2005 Long-Term Incentive Compensation Plan (as amended) or 2019 Long-Term Incentive Compensation Plan. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. 5,559 of such RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant, with shares vesting on various dates between May 2022 and May 2025. 6,628 of such RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant, with shares vesting in May 2022 and May 2023. Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant. Reflects options granted on May 18, 2020 that vest in annual increments of 25% beginning on the first anniversary of the date of grant. Reflects options granted on May 14, 2019 that vest in annual increments of 25% beginning on the first anniversary of the date of grant. Reflects options granted on June 11, 2018 that vest in annual increments of 25% beginning on the first anniversary of the date of grant. Reflects options granted on June 6, 2017 that vest in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Mr. Nikel 2021-08-16